BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 5:16:00 PM | Browse: 1320 | Download: 2019
 |
Received |
|
2013-11-22 07:11 |
|
Peer-Review Started |
|
2013-11-22 11:18 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-01-12 17:51 |
|
Revised |
|
2014-02-13 02:42 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-03-19 13:57 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-03-19 14:58 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-05-09 10:37 |
|
Publish the Manuscript Online |
|
2014-05-28 11:45 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Carlos Aguado, Beatriz García-Paredes, Miguel Jhonatan Sotelo, Javier Sastre and Eduardo Díaz-Rubio |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Eduardo Díaz-Rubio, MD, PhD, Department of Medical Oncology, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Martín Lagos, s/n, 28040 Madrid, Spain. ediazrubio.hcsc@salud.madrid.org |
| Key Words |
Capecitabine; 5-Fluorouracil; Metastatic colorectal cancer |
| Core Tip |
Although there is still controversy about whether capecitabine-based regimes can replace 5-fluorouracil (5-FU) in clinical practice in the treatment of first-line metastatic colon cancer, we have reviewed most of different randomized studies and meta-analyses, and we can conclude that capecitabine appear to be an effective, safe, convenient, and economically viable alternative to 5-FU. |
| Publish Date |
2014-05-28 11:45 |
| Citation |
Aguado C, García-Paredes B, Sotelo MJ, Sastre J, Díaz-Rubio E. Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer? World J Gastroenterol 2014; 20(20): 6092-6101
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i20/6092.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i20.6092 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
